Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients

INTRODUCTION: By targeting different subtypes of 5-hydroxytryptamine (5HT) receptors in the gastrointestinal (GI) tract, several drugs have been introduced for the management of irritable bowel syndrome (IBS). Renzapride is a full agonist for 5HT4 receptor and an antagonist to 5HT2b and 5HT3 recepto...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Termedia Publishing House 2014
Gaiak:
Systematic review/Meta-analysis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3953973/
https://ncbi.nlm.nih.gov/pubmed/24701208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2014.40729
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak